X0407 4 2023-06-15 false 0001597553 Sage Therapeutics, Inc. SAGE 0001586660 Golumbeski George C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 true false false false false Stock Option (Right to Buy) 56.10 2023-06-15 4 A false 10000.00 0.00 A 2033-06-15 Common Stock 10000.00 10000.00 D The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan in accordance with the terms of the Amended and Restated Non-Employee Director Compensation Policy. The option will vest in full upon the earlier to occur of June 15, 2024 or the day immediately prior to the 2024 Annual Meeting of Sage's stockholders, subject to continued service as a director on such date. /s/ Jennifer Fitzpatrick, as Attorney-in-Fact for George Golumbeski 2023-06-16